 |
|
| |
|
|
|
|
|
 |
| |
|
| |
| |
|
|
Profile of Dr. Chinta Sanjeeva Kumari |
|
| |
| CURRICULAM VITAE |
| |
| Name |
: |
Dr. Chinta Sanjeeva Kumari |
| Nationality |
|
Indian |
| Martial Status |
|
Married. |
| Address |
: |
Residence:66, Santhi Nagar, Masab Tank, Hyderabad- 500028 |
| P.No |
: |
040-23372020 |
| E-Mail |
: |
cskumari62@gmail.com |
|
|
| |
| |
| Qualifications |
| |
| MBBS |
: |
Kurnool Medical College in 1985 from Sri Venkateshwara University, A.P |
| MD. ( R.T.) |
: |
Osmania Medical College/ MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad in 1995 through NTR University of Health Sciences, A.P |
|
| |
| |
| Medical Registration: |
| |
A.P. Medical Council, Hyderabad, No. 17394
MBBS: 29-07-1986
MD (RT): 31-1-1996
|
|
| |
| |
| Experience: |
| |
SNO. |
PERIOD |
EXPERIENCE |
1 |
1987-1991 |
Worked as Medical Officer, Singareni Collieries Co. Ltd. Ramagundam, Karim Nagar Dt, A.P. |
2 |
1991-1992 |
Civil Assistant Surgeon, A.P Medical & Health Sciences, Govt of A.P |
3 |
1992-1995 |
Post Graduation (Radiotherapy), Osmania Medical College, Hyderabad |
4 |
1996-2006 |
Assistant Professor of Radiotherapy, Osmania Medical College/ MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad |
5 |
2006-2010 |
Associate Professor of Radiotherapy, Rangaraya Medical College, Kakinada / MNJ Institute of Oncology & Regional Cancer Centre |
6 |
2010-2012 |
In charge Professor of Radiotherapy, Osmania Medical College/ MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad |
7 |
2012 – till date |
Professor of Radiotherapy, Osmania Medical College/ MNJ Institute of Oncology & Regional Cancer Centre, Hyderabad |
|
|
| SNO |
Experience in Drug/ Clinical Trials |
| 1 |
Protocol RFS2000-09(I): Titled“Phase III study of RFS 2000(9-Nitro Camptothesin) Versus most appropriate therapy in Refractory Pancreatic Cancer Patients” version dated February 9, 2000. |
| 2 |
Protocol No. 16005: A randomized Multi centric Phase III study comparing Peg Interferon X-2a with RoferonA, for the treatment of Locally Advanced Metastatic Renal Cell Carcinoma ( RCC) |
| 3 |
Protocol No. R115777-INT- 11: A Phase III, Double- Blind Placebo controlled trial of Gemcitabine plus R115777 in patients with Advanced Pancreatic Cancer |
| 4 |
Protocol CA 002-0: Multi centric study of Cremophor – Free Protein stabilized, Nano particle formation of Paclitaxel(AB-007) in patients with Stage IV Metastatic Breast Cancer |
| 5 |
Protocol CA 0022- old: Multicentric study of Cremophor – Free Protein stabilized, Nano Particle Formulation of Paclitxel ABI-007 in patients with stage IV Metastatic Breast Cancer |
| 6 |
UKCCR Adjuvant Breast Cancer Trial |
| 7 |
A multicentric, Randomized, Double blind Study of Iodoxifene 40 mg/ day Versus Tamoxifen 20 mg/ day as First line Hormonal Therapy of Metastatic Breast Cancer in Post menopausal woman |
| 8 |
Phase III Comparative study of Combination Treatment with TL CD-99 Liposomal Doxorubicin & Cyclophosphamide Vs Doxorubicin & Cyclophosphamide in Metastatic Breast Cancer Protocol 94CE32- 0652 |
|
| |
Publications: |
1. International Journal of Analylitical Bio-Science. |
- Oxidative stress/Nitrosative stress in Breast cancer
MOHINI AIYENGAR TUPURANI, CHIRANJEEVI PADALA, RAJESH G KUMAR,
KAUSHIK PURANAM, CHINTA SANJEEVA KUMARI AND SUREKHA H RANI
Received for Publication February 22,2013 Accepted For PUBLICATION February 28th ,2013, Page No’s from 14 to 20.
|
2. Gelatinase B (−1562C/T) polymorphism in tumor progression and invasion of breast cancer.
Tumor Biol. (2014) 35:1351–1356
DOI 10.1007/s13277-013-1181-5
PADALA CHIRANJEEVI & K. MRUDULA SPURTHI & N. SANTHOSHI RANI & G. RAJESH KUMAR &
T. MOHINI AIYENGAR & M. SARASWATI & G. SRILATHA & G. KISHORE KUMAR & SUDHA SINHA&
CHINTA SANJEEVA KUMARI & B. NAGARJUNA REDDY & S. VISHNUPRIYA & H. SUREKHA RANI
Received: 11 June 2013 /Accepted: 4 September2013 Published online:20December2013# International Society of Oncology and Biomarkers (ISOBM) 2013. Page No’s from 1351 to 1356 |
3. Endothelial nitric oxide synthase gene polymorphisms and haplotypes Associated with breast cancer susceptibility in Indian population
MOHINI AIYENGAR TUPURANI, CHIRANJEEVI PADALA, RAJESH KUMAR GALIMUDI,
KAUSHIK PURANAM, NIVAS SHYAMALA, ADILAKSHMI MADISETTY, SAJEEVA KUMARI CHINTA,
SUREKHA RANI HANUMANTH
|
4. Carcinoma Lung among south Indian female patients: a single institute Epidemiological study.
C.SANJEEVA KUMARI, M.ADILAKSHMI, JOHN WINKLE, APARNA SURYA DEVARA.
YEAR OF PUBLICATION: july,06th 2015 Volume No: 4/Issue54/Page No’s from 9327 to 9335 |
5. Clinical Behavior of Uterine Cervical Carcinoma in an Immunocompromised Renal Transplant Recipient with literature on the incidence, pathogenesis and Clinical Behavior.
M.ADILAKSHMI, C.SANJEEVA KUMARI, APARNA SURYA DEVARA.
YEAR OF PUBLICATION: April,16th 2015 Volume No: 4/Issue31/Page No’s from 5421 to 5427
|
6. Cerebellar Hemangioblastoma is it always with von hippel landau syndrome? A Rare case of literature.
M.ADILAKSHMI, JM LOKABHI REDDY, C.SANJEEVA KUMARI, APARNA SURYA DEVARA
YEAR OF PUBLICATION: April,30th 2015 Volume No: 4/Issue35/Page No’s from 6129 to 6137 |
|
| |
Personal Details:- |
| |
| |
Office
Residence |
|
Associate Professor, MNJ Institute of Oncology,
Red Hills, Hyderabad - 500004.
Ph: 040 23397000
66, Santhi Nagar, Masob tank,
Hyderabad - 500028
Ph: 040 23372020.
Mobile: 098488 20404 |
|
| |
| |
|
| |
|
|
| |
| |
|
|
| © 2017-18 MNJ Institute of Oncology. All Rights Reserved. |
 |
|
|
